NIQ Unveils BASES AI Screener: Helping CPG Brands Thrive in the Age of Hyper-Innovation

15.4.2025 15:00:00 CEST | Business Wire | Press Release

NielsenIQ (NIQ), a leader in consumer intelligence, officially launched BASES AI Screener, combining NIQ's expansive consumer panel datasets, extensive innovation database, and leading predictive models with AI's ability to mimic human reactions for idea screening. BASES AI Screener is now available in multiple markets, including the United States, United Kingdom, Germany, Brazil, and Indonesia, with continuing expansion in 2025.

To meet the evolving needs of today's innovators, NIQ has introduced—BASES AI Screener—a real-time idea screening platform powered by Generative AI (GenAI). By leveraging NIQ's extensive behavioral data from consumer panels, the tool creates synthetic respondents with distinct demographic and purchasing behavior profiles. These AI-powered panels are then engaged to provide ratings, open-ended feedback, and tailored recommendations, enabling users to quickly evaluate and prioritize innovation ideas.

Key Benefits of BASES AI Screener for CPG Companies:

Reliable & Predictive Insights: Combines GenAI with BASES metrics and database perspective to provide a reliable assessment of innovation potential, along with detailed feedback and recommendations for improvement.
Accelerated Timelines: Delivers innovation assessments in minutesthrough a DIY platform, allowing for faster innovation cycles and reduced overall timelines.
Cost-Effective Results: Provides high-quality insights at a fraction of the cost of traditional screening methods.

"With BASES AI Screener, we're redefining how innovation decisions are made," said Ramon Melgarejo, President Strategic Analytics & Insights at NIQ. "By combining real purchase behavior with the latest in generative AI, we're helping teams cut through the noise and focus on ideas that truly matter—those with real market potential."

Additional Features of BASES AI Screener:

Continuously Updated Synthetic Panels: Synthetic panels are constantly updated with NIQ behavioral data, ensuring current consumer purchasing dynamics are built in.
Data-Rich AI Personas: Provide valuable feedback on innovation drivers of interest and differentiation to accelerate optimization.
Intuitive DIY Workspace: Allows users to screen, learn, and improve their innovations efficiently.

This innovative tool addresses the challenges of managing a high volume of new ideas with flat research budgets and faster timelines, which is crucial for CPG companies in today's market. The launch of BASES AI Screener complements NIQ's growing suite of AI-powered capabilities—including the recent acquisition of Gastrograph AI, which advances the usage of AI for product development—and reinforces NIQ's commitment to helping clients innovate smarter. It also marks a key milestone in building the broader AI Innovation ecosystem within NIQ, designed to accelerate growth and transformation across the innovation lifecycle.

About NIQ

NielsenIQ (NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. NIQ combined with GfK in 2023, bringing together two industry leaders with unparalleled global reach. Our global reach spans over 90 countries, covering approximately 85% of the world’s population and more than $ 7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.

For more information, please visit www.niq.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250415888796/en/

Contacts

Media Contact:
Sweta.Patra@nielseniq.com

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press Release

Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Stable Outlook from Fitch Ratings, assigned on 12 June 2026. Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation of the company’s

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press Release

Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magic Quadrant confirms the shift has moved from pilot to boardroom priority. According to Gartner, Visionaries "understands where the market

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press Release

Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The valve features the company’s FREE next generation tissue treatment addressing the two main causes of calcification, phospholipids and aldehydes. Its proprietary LANCELOT advanced manufacturing process includes zero-pressure shaping and laser cutting of

Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale9.10.2026 15:00:00 CEST | Press Release

Ada, the pioneer in Agentic Customer Experience, today announced it has achieved the Amazon Web Services (AWS) Travel and Hospitality Competency. The designation recognizes Ada as an AWS Partner with demonstrated technical proficiency and proven customer success helping travel and hospitality brands resolve customer issues at scale. Ada joins a select group of 58 AWS Partners holding the competency, and it reflects a shared commitment to helping travel brands deliver service that holds up on their busiest, most unpredictable days. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009673638/en/ Ada earns AWS Travel and Hospitality Competency for resolving traveler issues at scale "Travel is where agentic customer service gets tested hardest. Demand spikes without warning, policies change by the hour, and customers are often stressed and far from home," said Mike Murchison, CEO and co-founder of Ada. "Our airline and hospitali

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom